Aicardi-Goutières syndrome is an inherited leukodystrophy with calcifying microangiopathy and abnormal central nervous system myelination. As fewer diagnostic computed tomographic (CT) scans are being performed due to increased availability of magnetic resonance imaging (MRI), there is a potential for missed diagnoses on the basis of calcifications. We review a series of patients with MRIs selected from IRB-approved leukodystrophy biorepositories to identify MRI patterns for recognition of early-onset AicardiGoutières syndrome and scored for a panel of radiologic predictors. Each individual predictor was tested against disease status using exact logistic regression. Features for pattern recognition of Aicardi-Goutières syndrome are temporal lobe swelling followed by atrophy with temporal horn dilatation, early global cerebral atrophy and visible calcifications, as evidenced by 94.44% of cases of Aicardi-Goutières syndrome correctly classified with a sensitivity of 90.9% and specificity of 96.9%. We identify a panel of MRI features predictive of Aicardi-Goutières syndrome in young patients that would differentiate it from other leukoencephalopathies.
fluid pleocytosis, increased cerebrospinal fluid alpha interferon, and a calcifying microangiopathy with abnormal central nervous system white matter. 6 Classically, this diagnosis is suspected when typical calcifications are identified on computed tomographic (CT) imaging in the appropriate clinical context.
Because of the increased availability of magnetic resonance imaging (MRI) and to concerns with exposure to radiation, fewer CT scans are now performed as part of a diagnostic evaluation. This may result in missed opportunities to diagnose Aicardi-Goutières syndrome, unless characteristic MRI patterns are identified that permit suspicion of the disorder and appropriate diagnostic testing. In addition, patients without calcifications at disease onset have been identified [7] [8] [9] [10] so that a lack of cerebral calcifications cannot be considered an exclusionary criterion. 7, 11, 12 For these reasons, it is important to explore the diagnostic utility of MRI in Aicardi-Goutières syndrome, in particular in early-onset cases in the first year of life. In addition to intracranial calcifications, Aicardi-Goutières syndrome has been associated with abnormal cerebral white matter and cerebral atrophy. [11] [12] [13] [14] [15] [16] White matter abnormalities may be either diffuse or with an anteroposterior gradient, including a swollen appearance of anterior frontal and anterior temporal gyri. 7, 17 Younger patients and patients with the anteroposterior gradient were also likely to have frontotemporal cysts as additional features. 7 Finally, early-onset atrophy is also a prominent finding in a majority of Aicardi-Goutières syndrome patients, 7 and it may be progressive, involving the entire cerebral hemispheres 7 and brainstem, 18 with relative cerebellar sparing. 7 Differential diagnosis of the combination of calcification, atrophy, and swollen frontal or temporal white matter with or without cysts is particularly challenging in the first 2 years of life, as these may be seen in a number of early-onset disorders of the white matter ( Figure 1 ). These include acquired white matter diseases, such as congenital infections (eg, cytomegalovirus or rubella). Additionally, certain inherited disorders of the white matter, or leukodystrophies, can demonstrate overlapping radiologic findings. These include Alexander disease (presence of cysts and frontal predominance), megalencephalic leukoencephalopathy with subcortical cysts (prominent temporal involvement and cysts), vanishing white matter disease (rarefaction of white matter, temporal cysts in severe variants), ribonuclease T2 (RNaseT2)-related disease (temporal lobe cysts), rubella, mitochondrial leukoencephalopathies (temporal lobe involvement), various types of congenital muscular dystrophies (Fukuyama congenital muscular dystrophy, WalkerWarburg syndrome, congenital muscular dystrophy type 1D) (temporal lobe involvement), and leukoencephalopathy with calcifications and cysts (cysts and calcifications).
We sought to identify a panel of MRI features predictive of Aicardi-Goutières syndrome in very young patients that would differentiate it from other white matter diseases that present with similar radiologic features and permit the clinician to order appropriate diagnostic testing.
Methods

Standard Protocol Approvals, Registrations, and Patient Consents
MRI images of patients with mutation-proven Aicardi-Goutières syndrome (AGS; n ¼ 23, including AGS1, n ¼ 14; AGS2 ¼ 3, AGS3 ¼ 3, AGS5 ¼ 3), infantile Alexander disease (n ¼ 9), megalencephalic leukoencephalopathy with subcortical cysts (n ¼ 5), congenital cytomegalovirus infection (n ¼ 4), leukoencephalopathy with calcifications and cysts (n ¼ 3), and vanishing white matter disease (n ¼ 9) were reviewed according to a standard protocol. Imaging studies from patients with proven leukodystrophies with infantile-onset were selected. Age at first MRI and basic clinical information was recorded. All patients were selected from an institutional review board (IRB)-approved biorepository of leukodystrophy subjects collected from clinical centers with expertise in these disorders. Informed consent was obtained from all the patients evaluated at Children's National Health System and the University of Manchester.
Radiologic Criteria
All MRIs were scored for a series of radiologic predictors, including cerebral, cerebellar, and brainstem atrophy; location of white matter abnormalities; presence within abnormal white matter of regions of hypointense T 2 signal or hyperintense T 1 signal suggesting areas of more normal myelin development or mineralization; more hyperintense T 2 signal in an irregular fashion in subcortical regions; evidence of white matter rarefaction on fluid-attenuated inversion recovery imaging, visibility of calcifications on standard T 1 and T 2 imaging (as confirmed with correlation by CT scan review) on MRI; basal ganglia signal abnormalities and atrophy; cystic changes within brain parenchyma; and the finding of swelling or focal atrophy of areas including the frontal or temporal lobes (Figure 2 ). MRIs were scored by a pediatric neuroradiologist (NK) who was blinded to the patient's diagnosis.
Statistical Analysis
Each individual predictor was tested against disease status (AicardiGoutières syndrome vs non-Aicardi-Goutières syndrome) using exact The images demonstrate early frontal and temporal lobe swelling (thin white arrow) that gives way to severe frontal and temporal lobe atrophy (thick white arrows), as well as the prominent global atrophy. Note also the T 2 dark signal abnormalities presumed to be calcifications present at 2 months and present at 17 months in the second patient (dashed arrows).
logistic regression. All predictors with a P value less than .05 were compared pairwise to determine which predictors exhibit collinearity. Unique predictors having a significant relationship with disease status were included in a stepwise logistic regression model (probability criteria for exclusion/inclusion set to 0.2). All predictors entered into the model had equal chance of retention/exclusion at each step. The final model was developed by combining results from the stepwise process and iteratively including/excluding predictors felt to be most clinically relevant while accessing model fit via the Bayesian information criterion. Odds ratios, P values, and 95% confidence intervals are reported for those predictors surviving the selection process. A classification table was prepared for this final model.
Results
All proposed predictors appeared individually statistically predictive of Aicardi-Goutières syndrome, with the exception of a thin corpus callosum, signal abnormalities in the basal ganglia and cerebellar white matter, and swollen-appearing white matter in the parietal regions. Exact logistic regression analysis of each variable against diagnosis of Aicardi-Goutières syndrome identified 13 variables with P values <.05 (Table 1) . However, multiple-variable logistic regression analysis identified a combined model that included only a few of these features (Table 2) . This correctly identified 94.44% of cases of Aicardi-Goutières syndrome present in this sample (sensitivity 90.91%, specificity 96.88%, positive predictive value 95.24%, negative predictive value 93.94%). These results were used in preparation of a diagnostic algorithm based on the proposed predictors of Aicardi-Goutières syndrome based on the retained clinical predictors (Figure 3 ).
Patient's ages were a mean 1.2 years, median 0.7 year, whereas controls were a mean 3.4 years, median 2.2 years. All patients whose data were available in both the AicardiGoutières syndrome and control groups were developmentally delayed early in their clinical presentations: 23/23 (100%) of Aicardi-Goutières syndrome cases and 23/23 (100%) of control cases. There was a higher frequency of gastrostomy tube feeding dependence in the Aicardi-Goutières syndrome population (11/16 where data were available or 69%) versus the control population (5/19 where data were available or 26%) (Supplementary Data Table 1 is available at http://jcn.sagepub.com/supplemental). Similarly, fewer of the Aicardi-Goutières syndrome patients than controls were ambulatory or verbal, though this may be in part a reflection of their younger age. Exact logistic regression was used in this analysis because of a small sample size.
Discussion
This approach develops an algorithm for early onset leukodystrophies, to aid in the analysis of MRIs felt to be possibly consistent with Aicardi-Goutières syndrome. The combination of temporal lobe swelling or temporal horn dilation, with progressive atrophy, in particular of the frontal lobe, appears fairly specific of Aicardi-Goutières syndrome. Also notable was the fact that when carefully sought, calcifications were often visible on standard T 1 and T 2 MRI images, and when identified were highly specific for Aicardi-Goutières syndrome. Together, these features can help suggest a diagnosis of Aicardi-Goutières syndrome, and can be used by the clinician to determine the need for a CT scan or specific MRI modalities to identify calcifications and may prompt molecular or biochemical testing.
It is important to note that this algorithm was developed from leukoencephalopathies with features that could be overlapping with Aicardi-Goutières syndrome, such as a temporal or frontal predominance of leukoencephalopathy or presence of calcifications, and still needs to be validated in a larger cohort of unsolved leukodystrophies. Additionally, this model is developed from and for patients with early-onset leukoencephalopathies and may not be pertinent in Aicardi-Goutières syndrome patients with later age of onset. 7 Additional limitations of the study included lack of perfect age matching of the samples. This is a reflection of the fact that these diseases have slightly different typical ages of onset, and therefore slightly different ages of available MRI studies. Also of note, a predominance of patients with Aicardi-Goutières syndrome in this study had mutations in TREX1, and patients with mutations in the other genes were underrepresented. This is in part determined by the fact that cases were selected based on early age at onset, and first imaging. Patients with TREX1 mutations are more likely to have an earlier onset and we cannot definitely exclude that the observed results-that is, the specificity of temporal pole swelling and cystic degenerationreflect the peculiar distribution of the mutated genes in our sample.
Finally, as is often the case in rare disease research, our small sample size limited the range of feasible statistical analyses. In order to decrease the risk of statistical overfitting, where the developed model is only applicable to the sample at hand and not generalizable to the population, we took an iterative approach where we evaluated each predictor and the effect of a combination of predictors to arrive at a model that balances fit to the data with generalizability. Despite the high quality of fit, our results were based on only 23 Aicardi-Goutières syndrome patients and 30 non-Aicardi-Goutières syndrome control subjects as evidenced by the very wide confidence intervals. As the number of leukoencephalopathies with similar MRI features are discovered and additional patients are found and included in the analysis, the results presented here may change. Additionally, although a number of other disorders may have overlapping radiologic features with Aicardi-Goutières syndrome, such as temporal or frontal lobe predominance, calcifications, and cysts, these typically have other characteristics that may permit pattern recognition. These non-AicardiGoutières syndrome relevant MRI characteristics were not scored, as our small sample size precluded the statistical analysis of a larger set of variables. For example, these include, in Alexander disease, findings of basal ganglia and brainstem findings as well as the extensive contrast enhancement; in megalencephalic leukoencephalopathy with subcortical cysts, persistently swollen gyri and late atrophy with sometimes extensive cysts; in vanishing white matter disease, significant rarefaction of affected white matter; and in leukoencephalopathy with calcifications and cysts, the globular nature of calcifications in large aggregates and the large intraparenchymal cysts.
The proposed algorithm therefore does not take into consideration the full complexity of recognizing a likely diagnosis in an individual MRI. The entire constellation of clinical and radiologic features should be appreciated in each patient during diagnostic workup. However, features of temporal lobe swelling followed by atrophy with temporal horn dilation, early global cerebral atrophy, and visible calcifications on MRI appears Figure 3 . MRI characteristics of unsolved early-infantile leukoencephalopathy. MRI analyses were used to identify a possible descriptive algorithm of features on MRI consistent with the diagnosis of Aicardi-Goutières syndrome (AGS). Features of radiologic findings from megalencephalic leukoencephalopathy with subcortical cysts (MLC), cytomegalovirus (CMV), vanishing white matter disease (VWM), Alexander disease (AxD), and Coats plus disease/leukoencephalopathy with calcifications and cysts (CP/LCC) are depicted. Note the features of temporal lobe swelling followed by atrophy with temporal horn dilatation, early global cerebral atrophy, and visible calcifications on MRI in young patients with Aicardi-Goutières syndrome. This appears to be a promising group of features for pattern recognition on MRI. *Temporal lobe swelling occurs in early infantile cases of vanishing white matter disease, whereas it is not an MRI feature found in late-onset vanishing white matter disease patients. In addition, early infantile cases frequently have anterior temporal cysts. **Indicates a generally rare feature but exceptions have been found. to be a promising group of features for pattern recognition on MRI in young patients with Aicardi-Goutières syndrome. These features may help a clinician recognize Aicardi-Goutières syndrome in an era where CT scans are less often performed, and there is a greater potential for missing the pathognomonic calcifications seen in this disorder. These diagnostic imaging markers present a phenotype that is useful in evaluating MRI features in the diagnosis of early Aicardi-Goutières syndrome versus other early-onset leukodystrophies, further validating previous descriptions of this early-onset Aicardi-Goutières syndrome phenotype. 7, 19 
